Statistics

Total Visits

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study125

Select a period of time:

Number of views in the range

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study32

Views

Views
December 20254
January 20261
February 20260
March 202611
April 20264
May 20268
June 20264
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States21
Germany2
Netherlands2
Colombia2
Switzerland1
Chile1
Ecuador1
Puerto Rico1
Uruguay1
 

Top cities views

Views
San Jose5
Groningen2
Santa Clara2
Frankfurt am Main2
Ashburn1
Baltimore1
Bogotá1
Canovanas1
Goldsboro1
Guayaquil1